Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Development of a new therapeutic procedure for the treatment of acute stroke

18.07.2013
Around a third of the approximately 262,000 people who fall victim to stroke every year in Germany die within one year – a further 40 percent have to reckon on permanent disabilities.

In most cases (85 percent), the stroke is caused by the occlusion of a blood vessel in the brain. This results in the affected area of the brain becoming undersupplied with blood and oxygen, causing nerve tissue to die off beyond retrieval. Despite intensive research activities, only inadequate treatment options are currently available. The medical engineering company MD-5 GmbH, founded with the support of Fraunhofer IZI, has set itself the goal of improving this situation using an innovative treatment method.

The therapy concept developed by MD-5 GmbH is based on a procedure which can specifically influence the blood flow in the brain using magnetic fields. So-called intelligent transcranial magnetic stimulation (iTMS) allows blood flow to be increased in defined regions of the brain, thus limiting damage caused by a stroke. “Several investigations and optimizations are still required before the technology can be introduced into clinical routine as a medical device. Together with the Fraunhofer IZI and Leipzig University Hospital, we look forward to continuing with the development of a prototype which is suitable for practice and preparing its market launch,” commented Dr. Mark K. Borsody, Founder and Chief Medical Officer, describing the cooperation work of the joint project.

“The Fraunhofer IZI is contributing its comprehensive expertise in the areas of stroke research and preclinical development. Expressive model systems are to verify both the safety and efficacy of the procedure. The procedure can then be optimized accordingly by our colleagues at MD-5, based on these investigations,” commented Dr. Antje Dreyer, Head of the Clinic-oriented Therapy Assessment Unit at Fraunhofer IZI, describing the Fraunhofer Institute's role in the project.

With the addition of MD-5 GmbH, founded in Leipzig in October 2012 as a subsidiary of the US company Lake Bioscience LLC, Fraunhofer IZI has managed to bring on board another international partner and increase investment in the biotechnology location of Saxony.

“We are very glad that we succeded in convincing our colleagues from Lake Biosciences to establish their european subsidiary in Leipzig / Saxony” adds Dr. Thomas Tradler, Head of Business Development at the Fraunhofer IZI.

The project, valued at a total of 1.4 million euros, is being funded through the Sächsische Aufbaubank (Saxon Development Bank) with a total of 1.1 million euros coming from the European Regional Development Fund (ERDF) and also from the Free State of Saxony.

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops specific problem solutions at the interfaces of medicine, life sciences and engineering. The Institute practices contract research for biotechnological, pharmaceutical and medical-technological companies, hospitals, diagnostic laboratories and research facilities. Within the Business Units of Agents, Cell Therapy, Diagnostic and Biobanking, the Institute develops, optimizes and validates methods, materials and products. The Institute's core competencies are located in the field of Regenerative Medicine, in particular in the indication areas of oncology, ischemia and autoimmune, inflammatory and infectious diseases. The Institute is clinically oriented and conducts quality checks and the GMP-compliant manufacture of investigational medicinal products. Moreover, the Institute provides support in obtaining manufacturing authorizations and approvals.

| Fraunhofer-Gesellschaft
Further information:
http://www.izi.fraunhofer.de

More articles from Medical Engineering:

nachricht 'Memtransistor' brings world closer to brain-like computing
22.02.2018 | Northwestern University

nachricht MRI technique differentiates benign breast lesions from malignancies
20.02.2018 | Radiological Society of North America

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>